Filing Details
- Accession Number:
- 0001209191-21-011888
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 16:44:22
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 16:44:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1357874 | Precision Biosciences Inc | DTIL | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769887 | R. Matthew Kane | C/O Precision Biosciences, Inc. 302 E. Pettigrew Street, Suite A-100 Durham NC 27701 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-16 | 21,514 | $0.04 | 1,875,525 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 9,697 | $13.30 | 1,865,828 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-17 | 21,514 | $0.04 | 1,887,342 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-17 | 9,705 | $12.28 | 1,877,637 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-16 | 21,514 | $0.00 | 21,514 | $0.04 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-17 | 21,514 | $0.00 | 21,514 | $0.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 236,654 | 2021-05-17 | No | 4 | M | Direct | |
| 215,140 | 2021-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 9,752 | Indirect | By Spouse |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
- Shares are held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
